Division of Pediatric and Adolescent Endocrinology Indira Gandhi Institute of Child Health Bengaluru India Division of Pediatric and Adolescent Endocrinology, Indira Gandhi Institute of Child Health, Bengaluru, India.
Arch Endocrinol Metab. 2024 Jul 30;68:e230239. doi: 10.20945/2359-4292-2023-0239. eCollection 2024.
Maturity-onset diabetes of the young (MODY) is a clinically heterogeneous group of monogenic diabetes characterized by onset at a young age and an autosomal dominant mode of inheritance. Notably, MODY accounts for 2%-5% of all diabetes cases, and its distinction from types 1 (T1DM) and 2 (T2DM) diabetes mellitus is often challenging. We report herein the cases of two girls and a boy who presented initially with diabetic ketoacidosis. In view of the strong family history of diabetes in all three of them, the diagnosis of MODY was considered and confirmed by molecular testing. The patient in Case 1 (a 10-year-old girl) had a variation in the HNF1A gene (MODY 3). The patient in Case 2 (a 13-year-old girl) had a variation in the HNF1B gene (MODY 5) and was also clinically diagnosed with HNF1B MODY due to short stature, abnormal renal function, renal cysts, unicornuate uterus, and diabetic ketoacidosis at presentation. The patient in Case 3 (a 14-year-old boy) had a variation in the KCNJ11 gene (MODY 13) and presented with diabetic ketoacidosis; after initially being treated as having T1DM, he developed progressive weight gain, acanthosis nigricans, and decreased requirement of insulin. The patients in Cases 1 and 3 were subsequently treated with oral sulfonylureas and insulin was gradually tapered and interrupted, resulting in drastic improvement in glucose control. The patient in Case 2 remained on insulin, as this is the appropriate management for MODY 5. This case series demonstrates that atypical cases of MODY with ketoacidosis do occur, underscoring the potential for this complication within the phenotypic spectrum of MODY. In patients with atypical presentations, a thorough family history taking may reveal the diagnosis of MODY.
青少年发病的成年型糖尿病(MODY)是一组临床异质性的单基因糖尿病,其特征为发病年龄较小且呈常染色体显性遗传模式。值得注意的是,MODY 占所有糖尿病病例的 2%-5%,其与 1 型(T1DM)和 2 型(T2DM)糖尿病的区分常常具有挑战性。我们在此报告了三个以糖尿病酮症酸中毒(DKA)为首发表现的患儿病例。鉴于他们三人的糖尿病家族史均较强,我们考虑并通过分子检测确诊为 MODY。病例 1(10 岁女孩)患者存在 HNF1A 基因突变(MODY 3)。病例 2(13 岁女孩)患者存在 HNF1B 基因突变(MODY 5),由于身材矮小、肾功能异常、肾囊肿、单角子宫和 DKA 起病,也被临床诊断为 HNF1B MODY。病例 3(14 岁男孩)患者存在 KCNJ11 基因突变(MODY 13),表现为 DKA;最初被误诊为 T1DM 后,他出现了进行性体重增加、黑棘皮病和胰岛素需求减少。病例 1 和 3 的患者随后接受了磺脲类药物治疗,胰岛素逐渐减量并停用,血糖控制得到显著改善。病例 2 的患者仍继续使用胰岛素,因为这是 MODY 5 的恰当治疗方法。本病例系列表明,确实存在以 DKA 为表现的不典型 MODY 病例,这突出了该并发症在 MODY 表型谱中的潜在可能性。对于表现不典型的患者,详细的家族史采集可能会揭示 MODY 的诊断。